IHE Holdings Information

IHE is an equity ETF with a total of 59 individual holdings. The top holdings are Eli Lilly and Company stock at 22.58%, Johnson & Johnson at 21.30%, Viatris at 5.44%, Royalty Pharma at 5.13%, and Merck & Co. at 4.38%.

Total Holdings

Top 10 Percentage

76.91%

Asset Class

Equity

ETF Category

Health

Assets

869.50M

PE Ratio

21.69

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	22.58%	198,677
2	JNJ	Johnson & Johnson	21.30%	817,502
3	VTRS	Viatris Inc.	5.44%	2,791,864
4	RPRX	Royalty Pharma plc	5.13%	850,909
5	MRK	Merck & Co., Inc.	4.38%	341,872
6	BMY	Bristol-Myers Squibb Company	4.24%	662,371
7	PFE	Pfizer Inc.	4.23%	1,455,274
8	JAZZ	Jazz Pharmaceuticals plc	3.84%	147,293
9	ELAN	Elanco Animal Health Incorporated	2.94%	1,204,384
10	ZTS	Zoetis Inc.	2.83%	331,655
11	AXSM	Axsome Therapeutics, Inc.	2.69%	102,648
12	CORT	Corcept Therapeutics Incorporated	1.49%	226,926
13	INDV	Indivior PLC	1.29%	302,643
14	LGND	Ligand Pharmaceuticals Incorporated	1.18%	47,709
15	LQDA	Liquidia Corporation	1.12%	166,624
16	CRNX	Crinetics Pharmaceuticals, Inc.	1.07%	248,487
17	OGN	Organon & Co.	0.95%	630,193
18	SUPN	Supernus Pharmaceuticals, Inc.	0.80%	139,011
19	TARS	Tarsus Pharmaceuticals, Inc.	0.70%	94,702
20	EWTX	Edgewise Therapeutics, Inc.	0.69%	179,694
21	NKTR	Nektar Therapeutics	0.64%	76,412
22	PBH	Prestige Consumer Healthcare Inc.	0.59%	114,741
23	DFTX	Definium Therapeutics, Inc.	0.58%	238,912
24	AMRX	Amneal Pharmaceuticals, Inc.	0.57%	411,694
25	ALMS	Alumis Inc.	0.55%	196,641

Showing 25 of 59 holdings

Subscribe to see the full list

Activate Now

As of May 14, 2026